Resolve Surgical Technologies
Stacy Novak currently serves as the Vice President of Regulatory & Clinical Affairs at Resolve Surgical Technologies, a position held since January 2022, after previously being the Director of Regulatory Affairs. Prior experience includes serving as Director of Regulatory Affairs at RTI Surgical® and Director of Regulatory Operations at Smiths Medical, where responsibilities encompassed managing teams, overseeing regulatory compliance, and leading processes for regulatory submissions and audits. Prior to these roles, Stacy held several positions at Vascular Solutions, culminating in a Senior Manager role, and demonstrated expertise in transitioning documentation systems to electronic formats, quality compliance auditing, and post-market surveillance management.
This person is not in any offices
Resolve Surgical Technologies
The story of Resolve Surgical Technologies begins in 1992, when we entered into the industry as Pioneer Surgical Technology, Inc. Shortly thereafter, In 1993, Pioneer launched its first full system of instruments and implants for a major orthopedic OEM partner. This system, along with many other systems that Pioneer had launched, are still regarded as best in class by surgeons and partners. Throughout the years, Pioneer had established itself as a major innovator across the orthopedic community. Then, in 2013, RTI Biologics acquired Pioneer Surgical Technology, Inc. to create RTI Surgical. Both companies saw great success as they worked together to expand both Tissue & Biologics and Metals platforms. In 2020, Montagu Private Equity LLP acquired RTI Surgical’s OEM business. In 2022, due to rapid growth and high industry demand of both divisions, the RTI Surgical Metals division spun off to become Resolve Surgical Technologies.